Skip to content

Comparison of 4 percent articaine infiltration and 2 percent lignocaine nerve block for anesthesia in DMH-affected primary second molars: A split-mouth randomized controlled trial.

Comparative clinical efficacy of 4 percent articaine infiltration versus 2 percent lignocaine IANB block for anesthiesia of DMH-affected primary second molar - Split mouth Randomised controlled trial - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102431
Enrollment
15
Registered
2026-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K029- Dental caries, unspecified

Interventions

Intervention1: 4% Articaine Infiltration: Group A (Test): 4% articaine with 1:100,000 adrenaline will be administered via buccal infiltration at the DMH affected second primary molar site. Group B (C
in split-mouth design the contralateral appointment will receive the alternative intervention. Onset & assessment: Record onset time (time to subjective numbness) and test objective anesthesia (cold/

Sponsors

Saveetha dental college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 4 to 8 years requiring dental treatment for bilateral DMH-affected primary second molars in the mandible. Children diagnosed with dentin hypersensitivity/dentin mineralization hypoplasia (DMH) involving primary second molars, confirmed clinically and radiographically. Teeth indicated for restorative treatment or pulpal therapy requiring local anesthesia. Children classified as ASA Physical Status I or II. Children exhibiting positive or definitely positive behavior (Frankl Behavior Rating Scale). Availability of bilaterally comparable teeth, allowing a split-mouth study design. Children whose parents or legal guardians provide written informed consent, with assent obtained from the child where appropriate.

Exclusion criteria

Exclusion criteria: Exclusion Criteria Children with a known allergy or hypersensitivity to articaine, lignocaine, or amide local anesthetics. Children with systemic diseases, bleeding disorders, or neurological conditions that contraindicate local anesthesia administration. Children with acute dental infection, abscess, cellulitis, or swelling in the region of the involved teeth. Teeth with advanced pathological root resorption, periapical pathology, or mobility exceeding physiological limits. Children who had received analgesics, sedatives, or local anesthesia within 24 hours prior to the dental procedure. Children with negative behavior (Frankl Rating I or II) that could compromise the administration or assessment of local anesthesia. Children with a history of failed mandibular nerve block or anatomical abnormalities affecting nerve block efficacy. Children with special healthcare needs that could interfere with pain perception, communication, or cooperation during treatment.

Design outcomes

Primary

MeasureTime frame
Anesthetic Success Rate Assessed by the absence of pain during the dental procedure on the DMH-affected primary second molar following administration of the assigned anesthetic technique (4% articaine infiltration or 2% lignocaine inferior alveolar nerve block). Pain will be evaluated using an age-appropriate validated pain scale (e.g., Wong Baker FACES Pain Rating Scale) at the time of operative intervention.Timepoint: 0 days

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactRasika Chandak

Saveetha Dental College and Hospital.

152411004.sdc@saveetha.com7038376379

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026